Lawrence DA - Search Results

1

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

Huang Y, Haraguchi M, Lawrence DA, Border WA, Yu L, Noble NA. Huang Y, et al. Among authors: lawrence da. J Clin Invest. 2003 Aug;112(3):379-88. doi: 10.1172/JCI18038. J Clin Invest. 2003. PMID: 12897205 Free PMC article.

2

A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.

Huang Y, Border WA, Yu L, Zhang J, Lawrence DA, Noble NA. Huang Y, et al. Among authors: lawrence da. J Am Soc Nephrol. 2008 Feb;19(2):329-38. doi: 10.1681/ASN.2007040510. Epub 2008 Jan 23. J Am Soc Nephrol. 2008. PMID: 18216319 Free PMC article.

3

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.

Huang Y, Border WA, Lawrence DA, Noble NA. Huang Y, et al. Among authors: lawrence da. Am J Physiol Renal Physiol. 2009 Oct;297(4):F1045-54. doi: 10.1152/ajprenal.00024.2009. Epub 2009 Jul 22. Am J Physiol Renal Physiol. 2009. PMID: 19625379 Free PMC article.

4

A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes.

Zhang J, Gu C, Lawrence DA, Cheung AK, Huang Y. Zhang J, et al. Among authors: lawrence da. Exp Physiol. 2014 May 1;99(5):802-15. doi: 10.1113/expphysiol.2013.077610. Epub 2014 Jan 17. Exp Physiol. 2014. PMID: 24443353 Free PMC article.

5

Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.

Eitzman DT, Fay WP, Lawrence DA, Francis-Chmura AM, Shore JD, Olson ST, Ginsburg D. Eitzman DT, et al. Among authors: lawrence da. J Clin Invest. 1995 May;95(5):2416-20. doi: 10.1172/JCI117937. J Clin Invest. 1995. PMID: 7738206 Free PMC article.

6

Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.

Yepes M, Sandkvist M, Coleman TA, Moore E, Wu JY, Mitola D, Bugge TH, Lawrence DA. Yepes M, et al. Among authors: lawrence da. J Clin Invest. 2002 Jun;109(12):1571-8. doi: 10.1172/JCI14308. J Clin Invest. 2002. PMID: 12070304 Free PMC article.

7

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Yepes M, et al. Among authors: lawrence da. J Clin Invest. 2003 Nov;112(10):1533-40. doi: 10.1172/JCI19212. J Clin Invest. 2003. PMID: 14617754 Free PMC article.

8

Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Zhong J, Yang HC, Kon V, Fogo AB, Lawrence DA, Ma J. Zhong J, et al. Among authors: lawrence da. Lab Invest. 2014 Jun;94(6):633-44. doi: 10.1038/labinvest.2014.51. Epub 2014 Mar 31. Lab Invest. 2014. PMID: 24687120 Free PMC article.

9

Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.

Stefansson S, McMahon GA, Petitclerc E, Lawrence DA. Stefansson S, et al. Among authors: lawrence da. Curr Pharm Des. 2003;9(19):1545-64. doi: 10.2174/1381612033454621. Curr Pharm Des. 2003. PMID: 12871067 Review.

10

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1.

Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC, Lawrence DA. Stefansson S, et al. Among authors: lawrence da. J Biol Chem. 2001 Mar 16;276(11):8135-41. doi: 10.1074/jbc.M007609200. Epub 2000 Nov 16. J Biol Chem. 2001. PMID: 11083866 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters